Ir para o conteúdo principal
Materialise reports Q4 2025 results with medical revenue surging 16%
Image for illustrative purposes only. Not a real photo.

Materialise reports Q4 2025 results with medical revenue surging 16%

Compartilhar

Materialise (NASDAQ:MTLS) reported fourth-quarter financial results that showcased the growing dominance of its healthcare division, helping the company achieve a significant jump in profitability despite a mixed macroeconomic backdrop.